Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apriwell is a Berlin-based digital health company specializing in the treatment of chronic gastrointestinal conditions, with a primary focus on chronic constipation. The company offers a holistic, multi-modal therapy approach that combines a digital coaching application with personalized nutritional supplements and medical products. By integrating behavioral changes, dietary adjustments, and data-driven monitoring, Apriwell aims to provide long-term relief for patients who have not found success with traditional laxatives. Their platform is designed to address the root causes of digestive issues through a combination of telemedicine and self-management tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apriwell.